NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



A.P. Pharma, Inc.



A.P. Pharma Receives Extension for Nasdaq Listing Compliance



June 27th, 2009

A.P. Pharma, Inc. (Nasdaq: APPA), a specialty pharmaceutical company, announced that on May 29, 2009, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq) granting A.P. Pharma an extension to regain compliance with the minimum $10 million stockholders' equity requirement for continued listing on The Nasdaq Global Market under Nasdaq Marketplace Rule 5450(b)(1)(A). In April 2009, A.P. Pharma announced that it had received a letter from Nasdaq notifying the Company that it was not in compliance with this requirement.

Under the terms of this extension, on or before July 16, 2009, A.P. Pharma must furnish to the Securities and...


Source: Law & Health Weekly (2009-06-27)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login